(Total Views: 67)
Posted On: 10/17/2018 9:05:46 AM
Post# of 43879
$
HIPH
SeeThruEquity Issues Update, Doubles Price Target on American Premium Water Corp. (
HIPH
)
SeeThruEquity, an independent equity research and corporate access firm focused on smallcap and microcap public companies, recently issued a company update on American Premium Water (OTC: HIPH) and increased its initial price target to $0.30 from $0.15. The updated research follows the company’s recent launch of its CBD beverage, LALPINA Hydro CBD, as highlighted in the report. The company’s innovative product is the first of its kind on the market. Looking forward, the SeeThruEquity analysts believe that HIPH may be in a position to seek out partnerships for medical applications of a formulation of its product. Through its technology, the company could take advantage of a significant growth opportunity in a massive industry.
“Having American Premium’s price target revised upward by SeeThruEquity is a validation of management’s current plan. Over the past year, HIPH has transformed, entered one of the fastest growing sectors of the American economy (CBD), significantly reduced debt levels, made strategic acquisitions, entered into substantial distribution agreements, and, most importantly, positioned itself for substantial growth. The Company welcomes SeeThruEquity's continued research coverage and looks forward to supplying its analysts with more developments as we continue achieving our business plan targets in the near future,” American Premium Water CEO Ryan Fishoff stated in the news release.
SeeThruEquity, an independent equity research and corporate access firm focused on smallcap and microcap public companies, recently issued a company update on American Premium Water (OTC: HIPH) and increased its initial price target to $0.30 from $0.15. The updated research follows the company’s recent launch of its CBD beverage, LALPINA Hydro CBD, as highlighted in the report. The company’s innovative product is the first of its kind on the market. Looking forward, the SeeThruEquity analysts believe that HIPH may be in a position to seek out partnerships for medical applications of a formulation of its product. Through its technology, the company could take advantage of a significant growth opportunity in a massive industry.
“Having American Premium’s price target revised upward by SeeThruEquity is a validation of management’s current plan. Over the past year, HIPH has transformed, entered one of the fastest growing sectors of the American economy (CBD), significantly reduced debt levels, made strategic acquisitions, entered into substantial distribution agreements, and, most importantly, positioned itself for substantial growth. The Company welcomes SeeThruEquity's continued research coverage and looks forward to supplying its analysts with more developments as we continue achieving our business plan targets in the near future,” American Premium Water CEO Ryan Fishoff stated in the news release.
(0)
(0)
What I post is my opinion. Do your own DD. Make your own investment decision. Links, images, & retweets are not endorsements.
1️⃣I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
2️⃣All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
3️⃣I will not and cannot be held liable for any actions you take as a result of anything you read here.
4️⃣Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.
1️⃣I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
2️⃣All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
3️⃣I will not and cannot be held liable for any actions you take as a result of anything you read here.
4️⃣Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.
